// App-Quantinova.ai

3 : Retention Rates and Effectiveness of Abatacept at 12 Months: A Subgroup Analysis of the Canadian Population from the ACTION Study

Researchers

Presenter

  • Coralie Poncet

Principal Investigators

  • Majed Khraishi

  • Denis Choquette

  • Louis Bessette

  • William Bensen

  • Melanie Chartier

  • Hubert Nusslein

  • Rieke Alten

  • Manuela Le Bars

  • Carle Ryckman

Medical Centers

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • St. Josephs Hospital, McMaster University, Hamilton, ON, Canada

  • Schlosspark-Klinik University Medicine, Berlin, Germany

  • Universite Laval, Quebec, QC, Canada

Locations

  • Canada

  • Germany

Companies

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Abatacept

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim